Ramasastry Saira 4
4 · Mirum Pharmaceuticals, Inc. · Filed Dec 19, 2025
Insider Transaction Report
Form 4
Ramasastry Saira
Director
Transactions
- Exercise/Conversion
Common Stock
2025-12-18$23.51/sh+2,000$47,020→ 2,000 total - Sale
Common Stock
2025-12-18$69.46/sh−1,000$69,460→ 1,000 total - Sale
Common Stock
2025-12-18$70.00/sh−1,000$70,000→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2025-12-18−2,000→ 15,000 totalExercise: $23.51Exp: 2032-06-01→ Common Stock (2,000 underlying)
Footnotes (2)
- [F1]Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 18, 2025.
- [F2]The stock option is fully vested.